Target intelligence / Profile preview

SLC24A3 antisense RNA 2 (SLC24A3-AS2)

Target
SLC24A3-AS2
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA
01

Overview

SLC24A3 antisense RNA 2 (SLC24A3-AS2) is a long non-coding RNA transcribed from the opposite strand of the SLC24A3 gene locus. Antisense RNAs are typically involved in the regulation of their associated sense genes through a variety of mechanisms, including transcriptional interference, RNA-RNA duplex formation, and modulation of epigenetic states[1][2]. The specific function or biological roles of SLC24A3-AS2 have not been characterized in detail in humans; it is annotated as a novel transcript antisense to SLC24A3[3][7]. SLC24A3 itself encodes a sodium/potassium/calcium exchanger important in cellular calcium regulation, but SLC24A3-AS2 is a non-coding transcript. Notes on accuracy and ambiguity - is_incorrect: true — There is no evidence that "SLC24A3-AS2" itself is a conventional therapeutic target (such as a receptor, transporter, enzyme, etc.), nor is it currently described as a disease biomarker, drug target, or known to interact with drugs[3][7]. - Gene annotation: SLC24A3-AS2 is an RNA gene, not a protein-coding gene, and functions (if any) are consistent with general properties of antisense lncRNAs[1][2]. - Aliases: GeneCards lists "ENSG00000232675" as a novel transcript antisense to SLC24A3[3][7]. - Description: Due to absence of direct experimental data on SLC24A3-AS2, biological functions and disease involvement are inferred solely from the properties of similar antisense lncRNAs[1][2]. If you seek information on the protein-coding gene "SLC24A3" (Solute carrier family 24 member 3), it encodes a sodium/potassium/calcium exchanger membrane protein, but this is distinct from the lncRNA SLC24A3-AS2[6][8][9].

Other names
SLC24A3-AS2ENSG00000232675
02

Biological functions

Regulation of gene expression (likely at transcriptional or post-transcriptional levels via antisense mechanisms)

Beyond the preview

Go deeper on SLC24A3 antisense RNA 2 (SLC24A3-AS2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SLC24A3 antisense RNA 2 (SLC24A3-AS2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call